• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中重度化脓性汗腺炎患者 EQ-5D-5L 与 EQ-5D-3L 的测量性能比较。

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.

机构信息

Department of Health Economics, Corvinus University of Budapest, Fővám tér 8, H-1093, Budapest, Hungary.

Károly Rácz Doctoral School of Clinical Medicine, Semmelweis University, Üllői út 26, H-1085, Budapest, Hungary.

出版信息

Qual Life Res. 2021 May;30(5):1477-1490. doi: 10.1007/s11136-020-02732-x. Epub 2021 Feb 3.

DOI:10.1007/s11136-020-02732-x
PMID:33534032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068690/
Abstract

PURPOSE

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that affects up to 1% of the population in Europe. The EQ-5D is the most commonly used generic instrument for measuring health-related quality of life among HS patients. This study aims to compare the measurement properties of the two adult versions of EQ-5D (EQ-5D-3L and EQ-5D-5L) in patients with HS.

METHODS

We recruited 200 consecutive patients with HS (mean age 37 years, 38% severe or very severe HS) to participate in a multicentre cross-sectional survey. Patients completed the EQ-5D-3L, EQ-5D-5L, Dermatology Life Quality Index (DLQI) and Skindex-16 questionnaires.

RESULTS

More than twice as many different health state profiles occurred in the EQ-5D-5L compared to the EQ-5D-3L (101 vs. 43). A significant reduction in ceiling effect was found for the mobility, self-care and usual activities dimensions. A good agreement was established between the EQ-5D-3L and EQ-5D-5L with an intraclass correlation coefficient of 0.872 (95% CI 0.830-0.903; p < 0.001) that was confirmed by a Bland-Altman plot. EQ-5D-5L improved both the absolute and relative informativity in all dimensions except for anxiety/depression. EQ-5D-3L and EQ-5D-5L demonstrated similar convergent validity with DLQI and Skindex-16. EQ-5D-5L was able to better discriminate between known groups of patients based on the number of comorbidities and disease severity (HS-Physician's Global Assessment).

CONCLUSION

In patients with HS, the EQ-5D-5L outperformed the EQ-5D-3L in feasibility, ceiling effects, informativity and known-groups validity for many important clinical characteristics. We recommend using the EQ-5D-5L in HS patients across various settings, including clinical care, research and economic evaluations.

摘要

目的

化脓性汗腺炎(HS)是一种影响欧洲人群中高达 1%的慢性炎症性皮肤病。EQ-5D 是用于衡量 HS 患者健康相关生活质量的最常用的通用工具。本研究旨在比较 EQ-5D 的两种成人版本(EQ-5D-3L 和 EQ-5D-5L)在 HS 患者中的测量特性。

方法

我们招募了 200 名连续的 HS 患者(平均年龄 37 岁,38%为严重或非常严重的 HS)参加多中心横断面调查。患者完成了 EQ-5D-3L、EQ-5D-5L、皮肤病生活质量指数(DLQI)和 Skindex-16 问卷。

结果

EQ-5D-5L 比 EQ-5D-3L 出现的健康状态谱多了两倍以上(101 比 43)。在移动性、自我护理和日常活动维度上发现显著降低了天花板效应。EQ-5D-3L 和 EQ-5D-5L 之间建立了良好的一致性,组内相关系数为 0.872(95%置信区间 0.830-0.903;p<0.001),这通过 Bland-Altman 图得到了证实。EQ-5D-5L 在除焦虑/抑郁外的所有维度上都提高了绝对和相对信息量。EQ-5D-3L 和 EQ-5D-5L 与 DLQI 和 Skindex-16 均显示出相似的收敛效度。EQ-5D-5L 能够根据共病数量和疾病严重程度(HS-医生总体评估)更好地区分已知患者组。

结论

在 HS 患者中,EQ-5D-5L 在可行性、天花板效应、信息量和已知组有效性方面优于 EQ-5D-3L,可用于衡量 HS 患者的许多重要临床特征。我们建议在各种情况下(包括临床护理、研究和经济评估)在 HS 患者中使用 EQ-5D-5L。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/30e91b1b2e7f/11136_2020_2732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/3e91802c4ac3/11136_2020_2732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/30e91b1b2e7f/11136_2020_2732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/3e91802c4ac3/11136_2020_2732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/8068690/30e91b1b2e7f/11136_2020_2732_Fig2_HTML.jpg

相似文献

1
The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.中重度化脓性汗腺炎患者 EQ-5D-5L 与 EQ-5D-3L 的测量性能比较。
Qual Life Res. 2021 May;30(5):1477-1490. doi: 10.1007/s11136-020-02732-x. Epub 2021 Feb 3.
2
Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.EQ-5D-5L、Skindex-16、DLQI和DLQI-R在化脓性汗腺炎患者中的效度。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2584-2592. doi: 10.1111/jdv.16642. Epub 2020 Jul 2.
3
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.比较特应性皮炎患者 EQ-5D-3L 和 EQ-5D-5L 描述性系统的心理测量特性和效用。
Eur J Health Econ. 2023 Feb;24(1):139-152. doi: 10.1007/s10198-022-01460-y. Epub 2022 Apr 12.
4
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.在银屑病患者中,EQ-5D-5L与EQ-5D-3L相比的测量属性。
Qual Life Res. 2017 Dec;26(12):3409-3419. doi: 10.1007/s11136-017-1699-x. Epub 2017 Sep 5.
5
Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.银屑病中EQ-5D-3L和EQ-5D-5L工具的心理测量特性评估。
Arch Dermatol Res. 2017 Jul;309(5):357-370. doi: 10.1007/s00403-017-1743-2. Epub 2017 May 20.
6
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.克罗恩病患者的 EQ-5D-5L 和 EQ-5D-3L 的有效性。
Qual Life Res. 2019 Jan;28(1):141-152. doi: 10.1007/s11136-018-2003-4. Epub 2018 Sep 17.
7
Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.比较在中国农村生活的高血压患者中 EQ-5D-5L 和 EQ-5D-3L 的测量特性。
Qual Life Res. 2021 Jul;30(7):2045-2060. doi: 10.1007/s11136-021-02786-5. Epub 2021 Apr 5.
8
The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.在测量等待全髋关节置换术或全膝关节置换术的患者的健康相关生活质量方面,EQ-5D-5L 优于 -3L 版本。
Clin Orthop Relat Res. 2019 Jul;477(7):1632-1644. doi: 10.1097/CORR.0000000000000662.
9
Health-related quality of life in patients with lower limb amputation - an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry.下肢截肢患者的健康相关生活质量 - 使用瑞典截肢和假肢登记处的数据评估 EQ-5D-3L 和 EQ-5D-5L 的测量特性。
Disabil Rehabil. 2022 Dec;44(26):8471-8479. doi: 10.1080/09638288.2021.2015628. Epub 2021 Dec 21.
10
Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.比较伊朗普通人群中 EQ-5D-5L 和 EQ-5D-3L 的特性。
Int J Health Plann Manage. 2021 Sep;36(5):1613-1625. doi: 10.1002/hpm.3247. Epub 2021 May 20.

引用本文的文献

1
Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis.特应性皮炎、化脓性汗腺炎、天疱疮和银屑病患者健康相关生活质量的比较。
Arch Dermatol Res. 2025 Jan 18;317(1):291. doi: 10.1007/s00403-024-03786-4.
2
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases.比较慢性皮肤病患者的EQ-5D-5L、PROPr、SF-6D和TTO效用值。
Eur J Health Econ. 2025 Jun;26(4):627-639. doi: 10.1007/s10198-024-01728-5. Epub 2024 Sep 28.
3
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review.

本文引用的文献

1
Early health economic modelling for a treatment candidate in hidradenitis suppurativa.早期用于治疗化脓性汗腺炎候选药物的健康经济学建模。
J Med Econ. 2020 Dec;23(12):1516-1524. doi: 10.1080/13696998.2020.1840181. Epub 2020 Nov 9.
2
Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.匈牙利通过时间贸易偏好法对 EQ-5D-3L 和 EQ-5D-5L 进行平行评估。
Value Health. 2020 Sep;23(9):1235-1245. doi: 10.1016/j.jval.2020.03.019. Epub 2020 Aug 12.
3
The epidemiology of hidradenitis suppurativa.化脓性汗腺炎的流行病学
皮肤病生活质量指数(DLQI)用作101种生活质量工具验证的基准:一项系统评价。
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):631-679. doi: 10.1111/jdv.20321. Epub 2024 Sep 13.
4
Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata.斑秃患者中EQ-5D-5L量表的心理测量学特性
Pharmacoecon Open. 2024 Sep;8(5):715-725. doi: 10.1007/s41669-024-00504-8. Epub 2024 Jul 6.
5
Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000.匈牙利基于 EQ-5D-3L 的人群标准值 - 2022 年调查结果与 2000 年调查结果的比较。
Qual Life Res. 2024 Sep;33(9):2417-2428. doi: 10.1007/s11136-024-03699-9. Epub 2024 Jun 5.
6
Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease.迟发性庞贝病患者的 EQ-5D-3L、EQ-5D-5L 和 SF-6Dv2 的测量特性。
Eur J Health Econ. 2024 Dec;25(9):1505-1515. doi: 10.1007/s10198-024-01682-2. Epub 2024 Mar 12.
7
Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.匈牙利EQ-5D-5L、PROPr和SF-6D的人群常模。
Pharmacoeconomics. 2024 May;42(5):583-603. doi: 10.1007/s40273-024-01360-4. Epub 2024 Feb 28.
8
Societal costs and health related quality of life in adult atopic dermatitis.成人特应性皮炎的社会成本及健康相关生活质量。
BMC Health Serv Res. 2023 Aug 14;23(1):859. doi: 10.1186/s12913-023-09840-7.
9
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.患者对化脓性汗腺炎管理的偏好:欧洲多国离散选择实验的结果。
Patient. 2023 Mar;16(2):153-164. doi: 10.1007/s40271-022-00614-7. Epub 2023 Jan 11.
10
Health-Related Quality of Life and Utility Scores of Posttreatment Patients with Gastric Cancer at Different Pathological Stages: A Cross-Sectional Study.不同病理阶段胃癌治疗后患者的健康相关生活质量和效用评分:一项横断面研究
J Oncol. 2022 Apr 23;2022:2607829. doi: 10.1155/2022/2607829. eCollection 2022.
Br J Dermatol. 2020 Dec;183(6):990-998. doi: 10.1111/bjd.19435. Epub 2020 Sep 3.
4
Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.在泰国普通人群中,EQ-5D-5L 与 EQ-5D-3L 的心理测量学特性比较。
Qual Life Res. 2020 Dec;29(12):3407-3417. doi: 10.1007/s11136-020-02595-2. Epub 2020 Aug 11.
5
Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.EQ-5D-5L、Skindex-16、DLQI和DLQI-R在化脓性汗腺炎患者中的效度。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2584-2592. doi: 10.1111/jdv.16642. Epub 2020 Jul 2.
6
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.化脓性汗腺炎的延误诊断及其对患者和医疗保健系统的影响。
Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Epub 2020 Jul 1.
7
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.哪些多属性效用仪器推荐用于成本效用分析?国家卫生技术评估(HTA)指南的回顾。
Eur J Health Econ. 2020 Nov;21(8):1245-1257. doi: 10.1007/s10198-020-01195-8. Epub 2020 Jun 8.
8
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.化脓性汗腺炎:流行病学、表型、诊断、发病机制、合并症及生活质量的最新进展
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61. doi: 10.1111/jdv.16677. Epub 2020 Jul 16.
9
Exploring the relation between the EQ-5D-5L pain/discomfort and pain and itching in a sample of burn patients.探索烧伤患者样本中 EQ-5D-5L 疼痛/不适与疼痛和瘙痒之间的关系。
Health Qual Life Outcomes. 2020 May 19;18(1):144. doi: 10.1186/s12955-020-01394-0.
10
Exploring the EQ-5D Dimension of Pain/Discomfort in Dermatology Outpatients from a Multicentre Study in 13 European Countries.从 13 个欧洲国家的多中心研究探索皮肤科门诊患者的 EQ-5D 疼痛/不适维度。
Acta Derm Venereol. 2020 Apr 21;100(8):adv00120. doi: 10.2340/00015555-3477.